![Michael Bogda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Bogda
Directeur/Bestuurslid bij
Pharmaceutics International, Inc.
Profiel
Michael J.
Bogda is currently the Director at Pharmaceutics International, Inc. and an Advisor at Signet Healthcare Partners LLC.
Previously, he held positions as the Director at Apicore LLC from 2014 to 2015, VP-Operations & Facility General Manager at Copley Pharmaceutical, Inc., President & Chief Operating Officer at Lannett Co., Inc. from 2014 to 2016, Executive Vice President-Global Product Supply at Barr Pharmaceuticals, Inc. from 2000 to 2008, Executive VP-Americas Technical Operations at Teva Pharmaceuticals USA, Inc. in 2014, and President & Chief Operating Officer at Barr Laboratories, Inc. He obtained his undergraduate and graduate degrees from Rutgers State University of New Jersey and an MBA from The Wharton School of the University of Pennsylvania.
Actieve functies van Michael Bogda
| Bedrijven | Functie | Begin |
|---|---|---|
Pharmaceutics International, Inc.
 Pharmaceutics International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization that develops clinical and commercial volume aseptic filling, lyophilization & oral solid dose medicines | Directeur/Bestuurslid | - |
Signet Healthcare Partners LLC
 Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners invests in public and private companies across the globe. The fund targets companies operating in the fields of generic & specialty pharmaceuticals, pharmaceuticals services, medical devices and diagnostics. It provides financing for later and growth stage capital requirements with an investment size of USD 10 - 15 million. It makes co-investments and acts as lead investor with majority and minority investments. It also takes a seat on the board of directors. | Consultant / Adviseur | - |
Eerdere bekende functies van Michael Bogda
| Bedrijven | Functie | Einde |
|---|---|---|
| LANNETT COMPANY, INC. | President | 03-06-2016 |
Apicore LLC
 Apicore LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur/Bestuurslid | 01-03-2015 |
Teva Pharmaceuticals USA, Inc.
 Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Corporate Officer/Principal | 01-01-2014 |
Barr Laboratories, Inc.
 Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufacturers, and markets generic and proprietary pharmaceuticals | President | 01-12-2008 |
| BARR PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Opleiding van Michael Bogda
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
33
Eerstegraads connecties
10
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Copley Pharmaceutical, Inc.
 Copley Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Lannett Co., Inc.
 Lannett Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies generic pharmaceutical products | Health Technology |
Barr Pharmaceuticals, Inc.
 Barr Pharmaceuticals, Inc. Pharmaceuticals: GenericHealth Technology Manufactures & sells generic prescription pharmaceutical products | Health Technology |
Signet Healthcare Partners LLC
Signet Healthcare Partners LLC Investment ManagersFinance Signet Healthcare Partners invests in public and private companies across the globe. The fund targets companies operating in the fields of generic & specialty pharmaceuticals, pharmaceuticals services, medical devices and diagnostics. It provides financing for later and growth stage capital requirements with an investment size of USD 10 - 15 million. It makes co-investments and acts as lead investor with majority and minority investments. It also takes a seat on the board of directors. | Finance |
Rutgers State University of New Jersey
 Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Teva Pharmaceuticals USA, Inc.
Teva Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Manufacture and marketing generic pharmaceuticals | Health Technology |
Barr Laboratories, Inc.
Barr Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufacturers, and markets generic and proprietary pharmaceuticals | Health Technology |
Pharmaceutics International, Inc.
Pharmaceutics International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a contract development and manufacturing organization that develops clinical and commercial volume aseptic filling, lyophilization & oral solid dose medicines | Health Technology |
Apicore LLC
Apicore LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The Wharton School of the University of Pennsylvania
 The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
